AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21894054
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplement 1,520 IU/daily
Trial: 21894054
Drug: Ultraviolet radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultraviolet radiation B (UVB) 6 min weekly
Trial: 15482031
Drug: Ultrasound-guided thrombin
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided thrombin injection
Trial: 3043370
Drug: Imipramine (low,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (low, medium, and high doses)
Trial: 31337437
Drug: Behaviour change
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behaviour change intervention with classroom-based session (CBS) and SMS reminders to brush teeth twice daily
Trial: 25923275
Drug: Nasal saline
RxNorm normalized name: Nasal Saline
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nasal saline spray and a 3‐day course of antibiotics (either amoxicillin/clavulanate or levofloxacin)
Trial: 18653753
Drug: High-carbohydrate (HC)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-carbohydrate (HC) diet (7 g.kg(‐1).day(‐1))
Trial: 18653753
Drug: Low-carbohydrate (LC)
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-carbohydrate (LC) diet (2.9 g.kg(‐1).day(‐1))
Trial: 14503833
Drug: Crown-down technique
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crown-down technique with Greater Taper files (GT files) (Group 3)
Trial: 14503833
Drug: Step-back technique
RxNorm normalized name: Pep-Back
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Step-back technique with Greater Taper files (GT files) (Group 4)
Trial: 10915748
Drug: Lamivudine 150
RxNorm normalized name: lamivudine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine 150 mg/d orally for 12 weeks
Trial: 10915748
Drug: Lamivudine 150
RxNorm normalized name: lamivudine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine 150 mg/d plus famciclovir 500 mg 3 times a day orally for 12 weeks
Trial: 8831468
Drug: Methylphenidate administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate administered twice daily at a dose of .30 mg/kg
Trial: 8831468
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered according to the same schedule in identical pill form
Trial: 6585285
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (0.5 mg)
Trial: 6585285
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (1.0 mg)
Trial: 6585285
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (2.0 mg)
Trial: 31184016
Drug: Serenoa repens
RxNorm normalized name: Serenoa Repens Fruit
DrugBank: Saw palmetto (DB14360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serenoa repens in combination with Urtica dioiccus 160/120 mg twice daily for 3 months
Trial: 31184016
Drug: Serenoa repens
RxNorm normalized name: Serenoa Repens Fruit
DrugBank: Saw palmetto (DB14360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serenoa repens 320 mg once a day for 3 months
Trial: 12610802
Drug: Topical Tripterygium
RxNorm normalized name: Tripterygium wilfordii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Tripterygium wilfordii (TW)
Trial: 10730525
Drug: Intravenous indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous indomethacin (0.2 mg/kg initially, then 0.1 mg/kg every 12 hours for 2 more doses)
Trial: 7723643
Drug: Large fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large fluid replacement (Large FR) - 1330 +/- 60 ml of a 6% carbohydrate solution (79 +/- 4 g)
Trial: 7723643
Drug: Small fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small fluid replacement (Small FR) - 200 +/- 10 ml of a 40% maltodextrin solution (79 +/- 4 g)
Trial: 7723643
Drug: Carbohydrate ingestion
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate ingestion (CHO) - 6% carbohydrate solution (79 +/- 4 g)
Trial: 2119958
Drug: Intravenous tetrandrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tetrandrine (0.12 to 0.21 g)
Trial: 2119958
Drug: Intravenous tetrandrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tetrandrine
Trial: 31168688
Drug: Apixaban 2.5
RxNorm normalized name: apixaban 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apixaban 2.5 mg BD
Trial: 26787637
Drug: Target Controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Target Controlled Infusion (TCI)
Trial: 21596588
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics administered 5 minutes before exsanguination and inflation of the tourniquet (ABT)
Trial: 21596588
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics administered 1 minute after inflation of the tourniquet (AAT)
Trial: 17196059
Drug: Noradrenergic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noradrenergic and specific serotonergic antidepressant (NaSSA) mirtazapine
Trial: 17196059
Drug: Serotonin-norepinephrine reuptake
RxNorm normalized name: serotonin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine
Trial: 2929979
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg sublingual nifedipine
Trial: 26761270
Drug: Combination cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination cognitive behavioral therapy and medication management algorithm (COMB)
Trial: 20657612
Drug: Inhibitors of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhibitors of the renin-angiotensin system
Trial: 10413893
Drug: Sodium monofluorophosphate
RxNorm normalized name: Sodium Monofluorophosphate
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium monofluorophosphate (MFP) 15 mg F/day for 18 months
Trial: 10413893
Drug: Sodium fluoride
RxNorm normalized name: Sodium Fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium fluoride (NaF) 30 mg F/day for 18 months
Trial: 10413893
Drug: Sodium fluoride
RxNorm normalized name: Sodium Fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium fluoride (NaF) 30 mg F/day
Trial: 10413893
Drug: Sodium monofluorophosphate
RxNorm normalized name: Sodium Monofluorophosphate
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium monofluorophosphate (MFP) 15 mg F/day
Trial: 1900225
Drug: thrombin-antithrombin III
RxNorm normalized name: Thrombin-antithrombin III complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: thrombin-antithrombin III complex levels greater than 6 ng/l
Trial: 6132852
Drug: Metoclopramide, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide, 10 mg intramuscularly
Trial: 7065559
Drug: Metoclopramide, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide, 10 mg orally
Trial: 6132852
Drug: Bethanechol, 0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bethanechol, 0.07 mg/kg subcutaneously
Trial: 28257378
Drug: 0.2 μg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 μg/day fluocinolone acetonide (FAc)
Trial: 27281531
Drug: TEV‐48125 675/225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TEV‐48125 675/225 mg
Trial: 27281531
Drug: TEV‐48125 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TEV‐48125 900 mg
Trial: 22840457
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment group (GBT + conventional treatment)
Trial: 24286408
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment group (control group)
Trial: 17691587
Drug: Fe‐59 labeled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe‐59 labeled iron(III)‐hydroxide polymaltose complex (IPC, Maltofer) equivalent to 100 mg elemental iron
Trial: 17691587
Drug: Fe‐59 labeled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe‐59 labeled IPC complex equivalent to 100 mg elemental iron and 500 mg tetracycline HCl
Trial: 12011578
Drug: Soy milk
RxNorm normalized name: DIMETHICONE 4 g in 100 g CUTANEOUS PATCH [FERMENTED SOY MILK WRINKLE CARE SLEEPING MASK]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy milk providing 25 g/day of protein
Trial: 10445772
Drug: Remifentanil 1
RxNorm normalized name: remifentanil 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 1 microg/kg and placebo infusion
Trial: 10445772
Drug: Remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil infusion (remifentanil 1 microg/kg and infusion of 0.2 microg/kg/min)
Trial: 10445772
Drug: Alfentanil 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 7 microg/kg and placebo infusion
Trial: 7796715
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg i.v. cocaine
Trial: 1756260
Drug: High-dose megestrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose megestrol acetate (HDMA) at doses of 480, 800, 1280, and 1600 mg/d
Trial: 1756260
Drug: High-dose megestrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose megestrol acetate (HDMA)
Trial: 25406967
Drug: 1.5 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g/d eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as ready‐to‐eat meals enriched with liquid fish oil
Trial: 25406967
Drug: 1.5 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g/d eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as microencapsulated fish oil powder and regular meals
Trial: 9642510
Drug: MMF 2
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF 2 g/d
Trial: 9642510
Drug: MMF 3
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF 3 g/d
Trial: 19958860
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (rHuEpo) 200 U/kg daily for 3 consecutive days
Trial: 12201939
Drug: Intravesical IFN
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical IFN gamma (0.7 mg per week for 8 weeks)
Trial: 8567768
Drug: Human growth
RxNorm normalized name: Human growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human growth hormone (Norditropin, 12 IU/day, i.m., for 7 days)
Trial: 25301816
Drug: History of
RxNorm normalized name: BEMOTRIZINOL 0.8 mL in 100 mL / OCTINOXATE 7 mL in 100 mL TOPICAL CREAM [THE HISTORY OF WHOO GONG JIN HYANG HAE YOON SUN]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: History of excessive drinking and drug use
Trial: 17717235
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL water
Trial: 17717235
Drug: 300 mL
RxNorm normalized name: HYQVIA 30 GM / 300 ML Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mL water
Trial: 17717235
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of 300 mL vs 50 mL water
Trial: 11724848
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Isolator system and MYCO/F Lytic bottle
Trial: 3076051
Drug: Sodium fluoride
RxNorm normalized name: Sodium Fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium fluoride therapy
Trial: 7980801
Drug: New treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New treatment E
Trial: 7980801
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy S
Trial: 3060193
Drug: Ketanserin 20
RxNorm normalized name: ketanserin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin 20 mg three times a day for 1 week, then 40 mg three times a day for 4 weeks
Trial: 28947468
Drug: High DHA
RxNorm normalized name: Fish Oil/Stevia Extract 850 MG-10 MG Oral Packet [COROMEGA CHILD BRAIN & BODY HIGH DHA OMEGA-3]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High DHA fish oil capsules
Trial: 28947468
Drug: Control capsules
RxNorm normalized name: Azo Men Bladder Control Capsules(obs)
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control capsules without DHA
Trial: 26373743
Drug: Probiotics (Lactobacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (Lactobacillus acidophilus, Enterococcus faecium and Bifidobacterium infantum) at a dose of 0.6 × 107 colony‐forming units twice daily
Trial: 22647247
Drug: Fish protein
RxNorm normalized name: Fish Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish protein supplement (3 g/d for the first 4 weeks and 6 g/d for the last 4 weeks)
Trial: 21638149
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g ginger extracts
Trial: 1336762
Drug: Oral itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral itraconazole 200 mg daily for five days, then 200 mg twice weekly for six months
Trial: 1336762
Drug: Intravaginal clotrimazole
RxNorm normalized name: Clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal clotrimazole 200 mg ovules daily for five days, then 200 mg twice weekly for six months
Trial: 1336762
Drug: Oral itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral itraconazole after discontinuation of therapy
Trial: 1336762
Drug: Intravaginal clotrimazole
RxNorm normalized name: Clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal clotrimazole after discontinuation of therapy
Trial: 18345398
Drug: Cilazapril alone
RxNorm normalized name: cilazapril
DrugBank: Cilazapril (DB01340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril alone or cilazapril/hydrochlorothiazide/amlodipine combination therapy
Trial: 9366768
Drug: Sodium heparin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium heparin, EDTA, lithium heparin
Trial: 3935455
Drug: Metolazone (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metolazone (2.5 mg orally after 6 hours of furosemide infusion)
Trial: 3935455
Drug: Furosemide (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (4 mg h‐1 intravenous infusion for 12 hours)
Trial: 30082326
Drug: Exenatide QW
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide QW (2-mg subcutaneous injection) plus dapagliflozin (10-mg oral tablet)
Trial: 30082326
Drug: Exenatide QW
RxNorm normalized name: Exenatide
DrugBank: Exenatide (DB01276)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exenatide QW (2-mg subcutaneous injection)
Trial: 30082326
Drug: Dapagliflozin (10-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin (10-mg oral tablet)
Trial: 24780614
Drug: Eplerenone (25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone (25-50 mg once daily)
Trial: 9755021
Drug: Treatment groups
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment groups (A and B) vs Control group (C)
Trial: 3041785
Drug: Terodiline hydrochloride
RxNorm normalized name: Terodiline hydrochloride
DrugBank: Terodiline (DB13725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terodiline hydrochloride (24 mg/day)
Trial: 3041785
Drug: Flavoxate hydrochloride
RxNorm normalized name: Flavoxate Hydrochloride
DrugBank: Flavoxate (DB01148)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flavoxate hydrochloride (600 mg/day)
Trial: 18716827
Drug: Topical piroxicam
RxNorm normalized name: piroxicam Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical piroxicam
Trial: 28292867
Drug: Best Medical
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best Medical Therapy (Control)
Trial: 21944653
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (12 sessions of 30 minutes each)
Trial: 3557003
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg oral doses for 4 days)
Trial: 3557003
Drug: Indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (100 mg single oral dose)
Trial: 31329610
Drug: MERM device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MERM device with daily alert and scheduled dosing history review
Trial: 26082623
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with long-acting anticholinergic drugs
Trial: 23515006
Drug: DHA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA supplementation (1.16 g DHA/d)
Trial: 18188660
Drug: physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: physical therapy (hot pack, ultrasound, TENS) + home exercise
Trial: 12923829
Drug: Diazepam (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (12 or 18 mg/day)
Trial: 12923829
Drug: Diazepam (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (6 mg/day)
Trial: 11100393
Drug: Low-dose adrenomedullin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose adrenomedullin (ADM, 1, 2 and 3 pmol kg‐1 min‐1 for 30 min each)
Trial: 3901956
Drug: Nondominant unilateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nondominant unilateral electroconvulsive therapy (ECT)
Trial: 29926979
Drug: Lactobacillus reuteri
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus reuteri 6475 (1010 colony-forming units daily)
Trial: 27689192
Drug: Split-dose regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-dose regimen of sodium picosulfate/magnesium citrate (SPMC)
Trial: 25362223
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (enoxaparin), 0.5 mg/kg at the beginning of each hemodialysis session
Trial: 25362223
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UF heparin), 5000 units
Trial: 22647278
Drug: Jumping exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jumping exercise intervention (supervised jumping protocol during the first 10 min of physical education class, twice a week for 9 months)
Trial: 20306185
Drug: Metronidazole 500
RxNorm normalized name: metronidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 500 mg three times daily for 7 days
Trial: 3047920
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of iron per day, as ferrous gluconate
Trial: 29380821
Drug: Gluten (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gluten (10 g/daily)
Trial: 8607960
Drug: loratadine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: loratadine (10 mg by mouth daily)
Trial: 8607960
Drug: terfenadine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine (60 mg by mouth twice daily)
Trial: 24103462
Drug: Buccal fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal fat pad (BFP) (Group II, n = 10)
Trial: 23477161
Drug: Maixuekang capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maixuekang capsule combined with conventional therapy for 3 months
Trial: 29648531
Drug: Propafenone (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone (300 mg tablet)
Trial: 29648531
Drug: Ritmonorm® (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritmonorm® (300 mg tablet)
Trial: 17288686
Drug: Desloratadine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine 7.5 mg
Trial: 17288686
Drug: Desloratadine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine 7.5 mg plus alcohol (0.1% BAC)
Trial: 17288686
Drug: Desloratadine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine 7.5 mg vs. placebo with alcohol
Trial: 12140664
Drug: Flupirtine 50
RxNorm normalized name: FLUPIRTINE
DrugBank: Flupirtine (DB06623)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupirtine 50 mg